Suppression in vivo of human papillomavirus type 18 E6-E7 gene expression in nontumorigenic HeLa X fibroblast hybrid cells.
about
Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosisDifferential expression of the human ST5 gene in HeLa-fibroblast hybrid cell lines mediated by YY1: evidence that YY1 plays a part in tumor suppressionRetinoic acid-mediated repression of human papillomavirus 18 transcription and different ligand regulation of the retinoic acid receptor beta gene in non-tumorigenic and tumorigenic HeLa hybrid cellsMolecular events in uterine cervical cancer.Extinction of the HPV18 upstream regulatory region in cervical carcinoma cells after fusion with non-tumorigenic human keratinocytes under non-selective conditionsNucleolin as activator of human papillomavirus type 18 oncogene transcription in cervical cancerDifferential regulation of the JE gene encoding the monocyte chemoattractant protein (MCP-1) in cervical carcinoma cells and derived hybrids.Transcriptional activation of several heterologous promoters by the E6 protein of human papillomavirus type 16.Inverse relationship between human papillomavirus (HPV) type 16 early gene expression and cell differentiation in nude mouse epithelial cysts and tumors induced by HPV-positive human cell lines.Characterization of a novel human papillomavirus DNA in the cervical carcinoma cell line ME180.Human papillomaviruses and cervical neoplasia. II. Interaction of HPV with other factors.The enhancer in the long control region of human papillomavirus type 16 is up-regulated by PEF-1 and down-regulated by Oct-1.Repression of the human papillomavirus type 18 enhancer by the cellular transcription factor Oct-1.Progressive stages of "transdifferentiation" from epidermal to mesenchymal phenotype induced by MyoD1 transfection, 5-aza-2'-deoxycytidine treatment, and selection for reduced cell attachment in the human keratinocyte line HaCaT.
P2860
Q24532089-7B05FE02-1F48-4234-A3F1-392D981551F3Q24544034-A48FA3D6-6396-4896-A3B6-55B4D5D3E8B6Q33937895-39B2E01D-66F9-4D5D-8E49-9F05EDC1E95DQ35562096-D455EF8A-3FFD-4F77-A28C-743E3B695530Q35925163-BAD22B2F-B9F7-4121-8167-7ABC4095ACE0Q36371206-4FD13F05-B681-48DE-B4E8-F7E9D9979871Q36631278-BDFF7786-AA23-41C7-8884-0D02512C3C8BQ36656119-2086FDD7-04A9-450E-8300-B91E561EC52FQ36680176-51F9E108-4709-4A33-9E4F-E520BF5D6BEEQ36798489-7587D78D-D34A-4A73-9376-E319A2E89143Q37255166-E9C2EF98-3E7F-438D-8B03-B656BE8A9F25Q38293758-7ECDAB36-D087-4B8A-852F-0985FC438487Q40107396-9AE77261-BCDC-461F-B461-804429F55C9DQ41637982-CC9FE352-ABB3-4033-A116-C3FB2229AF26
P2860
Suppression in vivo of human papillomavirus type 18 E6-E7 gene expression in nontumorigenic HeLa X fibroblast hybrid cells.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Suppression in vivo of human p ...... eLa X fibroblast hybrid cells.
@en
type
label
Suppression in vivo of human p ...... eLa X fibroblast hybrid cells.
@en
prefLabel
Suppression in vivo of human p ...... eLa X fibroblast hybrid cells.
@en
P2093
P2860
P1433
P1476
Suppression in vivo of human p ...... HeLa X fibroblast hybrid cells
@en
P2093
P2860
P304
P407
P577
1990-10-01T00:00:00Z